Delivery Order SPE2DB22D1106-SPE2DB24FEUB0
Award Date 5/29/24
Potential Completion Date 5/30/24
Potential Value $30K
Federal Agency
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This federal contract award to AmerisourceBergen Drug Corp's Corporate Office Division is for the delivery of Trulicity 3 mg/0.5 ml pens, valued at $10,812.40. The contract is a firm-fixed price delivery order issued by the Defense Logistics Agency (DLA), a defense agency, with a completion date of July 2, 2024. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical worth up to $999,999,999.00 through December 31, 2025. This single-award IDC serves...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of one of the largest pharmaceutical distributors, is for the delivery of Trulicity 0.75 mg/0.5 ml pens to the Defense Logistics Agency (DLA). The $1,451.40 firm-fixed-price delivery order has a completion date of June 25, 2024 and was awarded on June 24, 2024. Amerisourcebergen holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to provide a comprehensive range of...
- This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division, a pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) for the delivery of Trulicity 1.5 mg/0.5 mL pens. The contract has a ceiling value of $3,047.94 and a period of performance through July 3, 2024. It was awarded as a firm-fixed-price delivery order, without any set-aside designation. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999.00...
- This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division, a major pharmaceutical supplier, was issued by the Defense Logistics Agency (DLA) for the delivery of Trulicity 1.5 mg/0.5 ml pens. The award, valued at $11,265.08, was made on a firm-fixed price basis without a set-aside designation. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999.00 through December 2025, which serves as the...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distribution company, for the delivery of Trulicity 1.5 mg/0.5 ml pens. The contract, valued at $1,451.40, is a Firm Fixed Price Delivery Order with a completion date of June 28, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025. This single-award...
- This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of Trulicity 0.75 mg/0.5 ml pens (0.5 ml) to the Defense Logistics Agency (DLA). The $1,306.26 firm-fixed price delivery order has a completion date of May 10, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical worth up to $999,999,999.00 through December 31, 2025, which serves as the primary vehicle for the company to provide a...
- This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division was issued by the Defense Logistics Agency (DLA) for the supply of Trulicity 1.5 mg/0.5 ml pens. The award, valued at $1,161.12, is a delivery order under an Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, which is valued up to $999,999,999.00 through December 31, 2025. This single-award IDC serves as the primary vehicle for Amerisourcebergen to deliver a...
- This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division, valued at $3,238.48, is for the delivery of Trulicity 0.75 mg/0.5 ml pen 0.5 ml to the Defense Logistics Agency (DLA). The contract is a firm-fixed-price delivery order with a completion date of May 14, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025, which serves as the primary vehicle for the...
- This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of Trulicity 1.5 mg/0.5 ml pens to the Defense Logistics Agency (DLA). The award, valued at $2,902.80, is a delivery order under a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical, worth up to $999,999,999.00 through December 2025. This single-award IDC serves as the primary vehicle for Amerisourcebergen to provide a comprehensive...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The contract, valued at $1,700.66, is for the delivery of Trulicity 1.5 mg/0.5 ml pens. This is a firm fixed-price delivery order contract with a completion date of May 14, 2024. The contract does not have a set-aside designation. Amerisourcebergen Drug Corp holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
- SPE2DB22D1106Indefinite Delivery Contract
- SPE2DB22D1106-SPE2DB24FEUB0Delivery Order
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division was issued by the Defense Logistics Agency (DLA) for the delivery of Trulicity 1.5 mg/0.5 ml medication pens. The contract, valued at $29,731.34, is a firm fixed-price delivery order with a completion date of May 30, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025, which serves as the primary vehicle for the company to deliver a wide range of pharmaceutical products and medical supplies to DLA facilities supporting the Department of Defense worldwide. This contract award does not have a set-aside designation.
Generated 8/28/24, 11:32 AM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $29.7k | 5/29/24 |